Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

androgen deprivation

  • You have access
    End-of-life Androgen Deprivation Syndrome With Enzalutamide in Metastatic Prostate Cancer: A Case Report
    MINH DUNG NGUYEN, OLENA GOROBETS, YANNICK JOEL DJOUA, JOHAN ROSE-DITE-MODESTINE, VINCENT VINH-HUNG, CLAIRE VERSCHRAEGEN and NAM P. NGUYEN
    Anticancer Research June 2025, 45 (6) 2535-2538; DOI: https://doi.org/10.21873/anticanres.17625
  • You have access
    Dose-escalated Radiation Therapy With and Without Short-course Androgen Deprivation for Intermediate-risk Prostate Cancer
    DAVID SCHREIBER, JUSTIN RINEER, APARNA SURAPANENI, ELLIOT NAVO, MANUJ AGARWAL, EMMANUEL NWOKEDI, MARVIN ROTMAN and DAVID SCHWARTZ
    Anticancer Research August 2014, 34 (8) 4189-4193;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire